Harrow, Inc. (HROW) stock
HROWNasdaqPharmaceutical PreparationsFiscal year ends December 31
$32.16+2.64 (+8.94%)
Close on Nov 18, 2026Market cap $1.21BP/E –Yield –
Harrow net income
Net income is the profit left for shareholders after every expense, interest and tax.
Harrow's net income for the twelve months ending Jun 30, 2026 was -$37.23M. For fiscal 2025 it was -$5.14M. The highest annual figure on record is $14.63M in fiscal 2018.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$5.14M | – |
| FY2024 | Dec 31, 2024 | -$17.48M | – |
| FY2023 | Dec 31, 2023 | -$24.41M | – |
| FY2022 | Dec 31, 2022 | -$14.09M | – |
| FY2021 | Dec 31, 2021 | -$18.01M | – |
| FY2020 | Dec 31, 2020 | -$3.36M | -2098.2% |
| FY2019 | Dec 31, 2019 | $168.00K | -98.9% |
| FY2018 | Dec 31, 2018 | $14.63M | – |
| FY2017 | Dec 31, 2017 | -$11.99M | – |
| FY2016 | Dec 31, 2016 | -$19.09M | – |
| FY2015 | Dec 31, 2015 | -$15.90M | – |
| FY2014 | Dec 31, 2014 | -$10.12M | – |
| FY2013 | Dec 31, 2013 | -$7.64M | – |
| FY2012 | Dec 31, 2012 | -$5.38M | – |
| FY2011 | Dec 31, 2011 | -$953.94K | – |
| FY2010 | Dec 31, 2010 | -$2.53M | – |
| FY2009 | Dec 31, 2009 | -$4.55M | – |
| FY2008 | Dec 31, 2008 | -$3.30M | – |
| FY2007 | Dec 31, 2007 | -$4.28M | – |
| FY2006 | Dec 31, 2006 | -$584.23K | – |
| FY2005 | Dec 31, 2005 | -$539.62K | – |
| FY2004 | Dec 31, 2004 | -$508.23K | – |
| FY2003 | Dec 31, 2003 | -$207.20K | – |
| FY2002 | Dec 31, 2002 | -$228.22K | – |
| FY2001 | Dec 31, 2001 | -$208.42K | – |
| FY2000 | Dec 31, 2000 | -$213.09K | – |
| FY1999 | Dec 31, 1999 | -$204.00K | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$17.27M | -445.7% |
| Q1 FY2026 | Mar 31, 2026 | -$27.60M | – |
| Q4 FY2025 | Dec 31, 2025 | $6.63M | -2.2% |
| Q3 FY2025 | Sep 30, 2025 | $1.02M | – |
| Q2 FY2025 | Jun 30, 2025 | $5.00M | – |
| Q1 FY2025 | Mar 31, 2025 | -$17.78M | – |
| Q4 FY2024 | Dec 31, 2024 | $6.78M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.22M | – |
| Q2 FY2024 | Jun 30, 2024 | -$6.47M | – |
| Q1 FY2024 | Mar 31, 2024 | -$13.57M | – |
| Q4 FY2023 | Dec 31, 2023 | -$9.15M | -967.1% |
| Q3 FY2023 | Sep 30, 2023 | -$4.39M | – |
| Q2 FY2023 | Jun 30, 2023 | -$4.23M | – |
| Q1 FY2023 | Mar 31, 2023 | -$6.64M | – |
| Q4 FY2022 | Dec 31, 2022 | $1.06M | – |
| Q3 FY2022 | Sep 30, 2022 | -$6.46M | – |
| Q2 FY2022 | Jun 30, 2022 | -$6.24M | – |
| Q1 FY2022 | Mar 31, 2022 | -$2.44M | -1223.5% |
| Q4 FY2021 | Dec 31, 2021 | -$7.42M | -745.6% |
| Q3 FY2021 | Sep 30, 2021 | -$8.33M | -196.4% |
| Q2 FY2021 | Jun 30, 2021 | -$2.48M | – |
| Q1 FY2021 | Mar 31, 2021 | $217.00K | – |
| Q4 FY2020 | Dec 31, 2020 | $1.15M | -56.8% |
| Q3 FY2020 | Sep 30, 2020 | $8.64M | – |
| Q2 FY2020 | Jun 30, 2020 | -$237.00K | – |
| Q1 FY2020 | Mar 31, 2020 | -$12.91M | -213.6% |
| Q4 FY2019 | Dec 31, 2019 | $2.66M | -85.3% |
| Q3 FY2019 | Sep 30, 2019 | -$11.47M | – |
| Q2 FY2019 | Jun 30, 2019 | -$2.38M | -194.3% |
| Q1 FY2019 | Mar 31, 2019 | $11.36M | – |
| Q4 FY2018 | Dec 31, 2018 | $18.13M | – |
| Q3 FY2018 | Sep 30, 2018 | -$2.51M | – |
| Q2 FY2018 | Jun 30, 2018 | $2.52M | +69.9% |
| Q1 FY2018 | Mar 31, 2018 | -$3.51M | – |
| Q4 FY2017 | Dec 31, 2017 | -$2.77M | – |
| Q3 FY2017 | Sep 30, 2017 | -$5.69M | – |
| Q2 FY2017 | Jun 30, 2017 | $1.48M | – |
| Q1 FY2017 | Mar 31, 2017 | -$5.01M | – |
| Q4 FY2016 | Dec 31, 2016 | -$6.10M | – |
| Q3 FY2016 | Sep 30, 2016 | -$3.85M | – |
See a number that looks wrong?